152 related articles for article (PubMed ID: 31113597)
21. Enzyme replacement therapy in lysosomal acid lipase deficiency (LAL-D): a systematic literature review.
Bashir A; Tiwari P; Duseja A
Ther Adv Rare Dis; 2021; 2():26330040211026928. PubMed ID: 37181111
[TBL] [Abstract][Full Text] [Related]
22. Lysosomal acid lipase deficiency: Expanding differential diagnosis.
Valayannopoulos V; Mengel E; Brassier A; Grabowski G
Mol Genet Metab; 2017; 120(1-2):62-66. PubMed ID: 27876313
[TBL] [Abstract][Full Text] [Related]
23. Does Lysosomial Acid Lipase Reduction Play a Role in Adult Non-Alcoholic Fatty Liver Disease?
Baratta F; Pastori D; Polimeni L; Tozzi G; Violi F; Angelico F; Del Ben M
Int J Mol Sci; 2015 Nov; 16(12):28014-21. PubMed ID: 26602919
[TBL] [Abstract][Full Text] [Related]
24. Dissecting cell type-specific impact in lysosomal acid lipase deficiency-associated disorders.
Westerterp M; Li F; Zhang H
J Lipid Res; 2023 Dec; 64(12):100474. PubMed ID: 37972729
[No Abstract] [Full Text] [Related]
25. Identification and metabolic profiling of patients with lysosomal acid lipase deficiency.
Pullinger CR; Stock EO; Movsesyan I; Malloy MJ; Frost PH; Tripuraneni R; Quinn AG; Ishida BY; Schaefer EJ; Asztalos BF; Kane JP
J Clin Lipidol; 2015; 9(5):716-26.e1. PubMed ID: 26350820
[TBL] [Abstract][Full Text] [Related]
26. Lysosomal acid lipase deficiency allograft recurrence and liver failure- clinical outcomes of 18 liver transplantation patients.
Bernstein DL; Lobritto S; Iuga A; Remotti H; Schiano T; Fiel MI; Balwani M
Mol Genet Metab; 2018 May; 124(1):11-19. PubMed ID: 29655841
[TBL] [Abstract][Full Text] [Related]
27. Opening a window on lysosomal acid lipase deficiency: Biochemical, molecular, and epidemiological insights.
Cappuccio G; Donti TR; Hubert L; Sun Q; Elsea SH
J Inherit Metab Dis; 2019 May; 42(3):509-518. PubMed ID: 30684275
[TBL] [Abstract][Full Text] [Related]
28. Infant case of lysosomal acid lipase deficiency: Wolman's disease.
Sadhukhan M; Saha A; Vara R; Bhaduri B
BMJ Case Rep; 2014 May; 2014():. PubMed ID: 24832708
[TBL] [Abstract][Full Text] [Related]
29. Sebelipase alfa: enzymatic replacement treatment for lysosomal acid lipase deficiency.
Paton DM
Drugs Today (Barc); 2016 May; 52(5):287-93. PubMed ID: 27376161
[TBL] [Abstract][Full Text] [Related]
30. Sebelipase alfa over 52 weeks reduces serum transaminases, liver volume and improves serum lipids in patients with lysosomal acid lipase deficiency.
Valayannopoulos V; Malinova V; Honzík T; Balwani M; Breen C; Deegan PB; Enns GM; Jones SA; Kane JP; Stock EO; Tripuraneni R; Eckert S; Schneider E; Hamilton G; Middleton MS; Sirlin C; Kessler B; Bourdon C; Boyadjiev SA; Sharma R; Twelves C; Whitley CB; Quinn AG
J Hepatol; 2014 Nov; 61(5):1135-42. PubMed ID: 24993530
[TBL] [Abstract][Full Text] [Related]
31. Could lysosomal acid lipase enzyme activity be used for clinical follow-up in cryptogenic cirrhosis?
Köse E; Çağatay E; Yaraş T; Kısa PT; Güler S; Gülten ZA; Akarsu M; Oktay Y; Kayalı HA; Arslan N
Turk J Med Sci; 2022 Aug; 52(4):1075-1084. PubMed ID: 36326406
[TBL] [Abstract][Full Text] [Related]
32. Sebelipase Alfa: A Review in Lysosomal Acid Lipase Deficiency.
Frampton JE
Am J Cardiovasc Drugs; 2016 Dec; 16(6):461-468. PubMed ID: 27878737
[TBL] [Abstract][Full Text] [Related]
33. Sebelipase alfa improves atherogenic biomarkers in adults and children with lysosomal acid lipase deficiency.
Wilson DP; Friedman M; Marulkar S; Hamby T; Bruckert E
J Clin Lipidol; 2018; 12(3):604-614. PubMed ID: 29628368
[TBL] [Abstract][Full Text] [Related]
34. Metabolic changes and propensity for inflammation, fibrosis, and cancer in livers of mice lacking lysosomal acid lipase.
Bradić I; Liesinger L; Kuentzel KB; Vujić N; Trauner M; Birner-Gruenberger R; Kratky D
J Lipid Res; 2023 Sep; 64(9):100427. PubMed ID: 37595802
[TBL] [Abstract][Full Text] [Related]
35. Initial assessment and ongoing monitoring of lysosomal acid lipase deficiency in children and adults: Consensus recommendations from an international collaborative working group.
Kohli R; Ratziu V; Fiel MI; Waldmann E; Wilson DP; Balwani M
Mol Genet Metab; 2020 Feb; 129(2):59-66. PubMed ID: 31767214
[TBL] [Abstract][Full Text] [Related]
36. Long-term survival with sebelipase alfa enzyme replacement therapy in infants with rapidly progressive lysosomal acid lipase deficiency: final results from 2 open-label studies.
Vijay S; Brassier A; Ghosh A; Fecarotta S; Abel F; Marulkar S; Jones SA
Orphanet J Rare Dis; 2021 Jan; 16(1):13. PubMed ID: 33407676
[TBL] [Abstract][Full Text] [Related]
37. Expression and functional characterization of human lysosomal acid lipase gene (LIPA) mutation responsible for cholesteryl ester storage disease (CESD) phenotype.
Rajamohan F; Reyes AR; Ruangsiriluk W; Hoth LR; Han S; Caspers N; Tu M; Ward J; Kurumbail RG
Protein Expr Purif; 2015 Jun; 110():22-9. PubMed ID: 25620107
[TBL] [Abstract][Full Text] [Related]
38. A Phase 3 Trial of Sebelipase Alfa in Lysosomal Acid Lipase Deficiency.
Burton BK; Balwani M; Feillet F; Barić I; Burrow TA; Camarena Grande C; Coker M; Consuelo-Sánchez A; Deegan P; Di Rocco M; Enns GM; Erbe R; Ezgu F; Ficicioglu C; Furuya KN; Kane J; Laukaitis C; Mengel E; Neilan EG; Nightingale S; Peters H; Scarpa M; Schwab KO; Smolka V; Valayannopoulos V; Wood M; Goodman Z; Yang Y; Eckert S; Rojas-Caro S; Quinn AG
N Engl J Med; 2015 Sep; 373(11):1010-20. PubMed ID: 26352813
[TBL] [Abstract][Full Text] [Related]
39. Lysosomal acid lipase deficiency--an under-recognized cause of dyslipidaemia and liver dysfunction.
Reiner Ž; Guardamagna O; Nair D; Soran H; Hovingh K; Bertolini S; Jones S; Ćorić M; Calandra S; Hamilton J; Eagleton T; Ros E
Atherosclerosis; 2014 Jul; 235(1):21-30. PubMed ID: 24792990
[TBL] [Abstract][Full Text] [Related]
40. Recent insights into lysosomal acid lipase deficiency.
Korbelius M; Kuentzel KB; Bradić I; Vujić N; Kratky D
Trends Mol Med; 2023 Jun; 29(6):425-438. PubMed ID: 37028992
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
